Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5418154 | 0.76 | — | — | |
| SCHEMBL10097850 | 0.74 | — | — | |
| SCHEMBL25953602 | 0.74 | GAA (0.33) | — | |
| SCHEMBL4530241 | 0.68 | GAA (0.30) | — | |
| SCHEMBL8016425 | 0.67 | MEN1 (0.34) | — | |
| SCHEMBL9421996 | 0.67 | — | — | |
| SCHEMBL3875955 | 0.67 | KDM4E (0.30) | — | |
| SCHEMBL18239351 | 0.67 | — | — | |
| SCHEMBL8020079 | 0.59 | MAPK1 (0.34) | — | |
| SCHEMBL1131513 | 0.59 | PDE3B (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-61184535-A | — | — | None | — | — | JP | disclosed |
| EP-3033558-A1 | METHOD AND SYSTEM FOR SUPPORTING SUBMERGED STRUCTURES | Subcon Technologies Pty Ltd. (AU) | 2016-06-22 | — | — | EP | disclosed |
| US-20160161024-A1 | METHOD AND SYSTEM FOR SUPPORTING SUBMERGED STRUCTURES | SUBCON TECHNOLOGIES PTY LTD. (AT) | 2016-06-09 | — | — | US | disclosed |
| US-8354433-B2 | Anti-inflammatory agents as virostatic compounds | 4SC AG (DE) | 2013-01-15 | — | — | US | disclosed |
| US-20100280081-A1 | ANTI-INFLAMMATORY AGENTS AS VIROSTATIC COMPOUNDS | 4SC AG (DE) | 2010-11-04 | — | — | US | disclosed |
| US-7659012-B2 | layered inorganic silicates, epoxy resin polymer, curing agent to form nanocomposite encapsulation layer and adhere first substrate to the second; prevent moisture and oxygen absorption | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2010-02-09 | — | — | US | disclosed |
| EP-1631597-A4 | DISPLACEABLE LINKER SOLID PHASE CHEMICAL LIGATION | GRYPHON THERAPEUTICS INC (US) | 2007-07-11 | — | — | EP | disclosed |
| EP-1631597-A2 | DISPLACEABLE LINKER SOLID PHASE CHEMICAL LIGATION | Gryphon Therapeutics, Inc. (US) | 2006-03-08 | — | — | EP | disclosed |
| US-20050170210-A1 | Organic electroluminescent display device | SAMSUNG DISPLAY CO., LTD. (KR) | 2005-08-04 | — | — | US | disclosed |
| WO-2004105685-A2 | DISPLACEABLE LINKER SOLID PHASE CHEMICAL LIGATION | GRYPHON THERAPEUTICS, INC. (US) | 2004-12-09 | — | — | WO | disclosed |
| US-5962533-A | ANTITUMOR AGENTS; ANTIDIARRHEA AGENT | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 1999-10-05 | — | — | US | disclosed |
| US-4632960-A | STRENG, NON CORROSIVE, NON SHRINKING; METAL-FREE EMULSION POLYMERIZATION | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1986-12-30 | — | — | US | disclosed |
| JP-S61184535-A | OPTICAL RECORDING MEDIUM | NIPPON TELEGR & TELEPH CORP <NTT> | 1986-08-18 | — | — | JP | disclosed |
| US-4469771-A | POLYMERIC PROTECTIVE COATING CONTAINING LEWIS ACID | RICOH CO., LTD. (JP) | 1984-09-04 | — | — | US | disclosed |
| US-4225648-A | PROTECTIVE COATING OF POLYMER CONTAINING LEWIS ACID | RICOH COMPANY, LTD. (JP) | 1980-09-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100280081-A1 | ANTI-INFLAMMATORY AGENTS AS VIROSTATIC COMPOUNDS | TNF, MIF, IL1B | TP53 1801/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.